Pfizer Inc. reports $16.58 billion revenue for quarter ended September 27, 2026, down 0.4%
Pfizer Inc. reported revenue of $16.58 billion for the quarter ended September 27, 2026, a decrease of 0.4% from the same quarter a year earlier ($16.65 billion).
For the same period it posted net income of $3.24 billion, down 8.4%, or $0.56 per diluted share (0.62 a year earlier).
That is a net margin of 19.6%.
On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).
Is Pfizer Inc. halal?
See the full AAOIFI screening of Pfizer Inc.
See the full AAOIFI screening of Pfizer Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on November 3, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.